Skip to content
  • Mon. May 12th, 2025

Producers Online

Producers Online

  • Home
  • Producers online

Latest Post

Tim Lamb Group Welcomes Paul Gilroy To Their Team of Directors Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025 Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt Akero Therapeutics présente les résultats de la 96e semaine de l’essai clinique de phase 2b SYMMETRY sur l’éfruxifermine chez des patients atteints de cirrhose compensée causée par une stéatohépatite associée à un dysfonctionnement métabolique (MASH), montrant une amélioration de la fibrose sans aggravation de la MASH lors du congrès 2025 de l’EASL
Producers

Tim Lamb Group Welcomes Paul Gilroy To Their Team of Directors

May 12, 2025 admin
Producers

Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025

May 12, 2025 admin
Producers

Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine

May 12, 2025 admin
Producers

Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt

May 12, 2025 admin
Producers

Akero Therapeutics présente les résultats de la 96e semaine de l’essai clinique de phase 2b SYMMETRY sur l’éfruxifermine chez des patients atteints de cirrhose compensée causée par une stéatohépatite associée à un dysfonctionnement métabolique (MASH), montrant une amélioration de la fibrose sans aggravation de la MASH lors du congrès 2025 de l’EASL

May 12, 2025 admin
  • Latest
  • Popular
  • Trending
Tim Lamb Group Welcomes Paul Gilroy To Their Team of Directors
Producers
Tim Lamb Group Welcomes Paul Gilroy To Their Team of Directors
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Producers
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine
Producers
Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine
Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt
Producers
Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt
Brazil upholds 18% tariff on US ethanol imports
Producers
Brazil upholds 18% tariff on US ethanol imports
AACC rebrands itself
Producers
AACC rebrands itself
Vital role of food, agriculture explored in ABA study
Producers
Vital role of food, agriculture explored in ABA study
Wheat Quality Council highlights sustainability, regulation, nutrition
Producers
Wheat Quality Council highlights sustainability, regulation, nutrition
Tim Lamb Group Welcomes Paul Gilroy To Their Team of Directors
Producers
Tim Lamb Group Welcomes Paul Gilroy To Their Team of Directors
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Producers
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine
Producers
Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine
Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt
Producers
Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt
Producers

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

September 28, 2024 admin

Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology,…

Producers

Form 8.3 – [KEYWORDS STUDIOS PLC – 26 09 2024]

September 28, 2024 admin

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…

Producers

Arqit announces leadership transition with the appointment of a new Chief Executive Officer

September 28, 2024 admin

LONDON, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW), a leading provider of quantum-safe encryption, today announced a leadership transition. Andy Leaver, a seasoned software company…

Producers

Peptide Therapeutics Market to Witness 5.94% CAGR by 2031

September 28, 2024 admin

Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Peptide Therapeutics Market will attain the value of USD 68.4 Billion by 2031, with a CAGR of 5.94% during…

Producers

Drug Screening Market to Reach Market Valuation of USD 35.18 Billion by 2031

September 27, 2024 admin

Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Drug Screening Market will reach a value of USD 35.18 Billion by 2031, with a CAGR of…

Producers

Eyewear Market to Surpass Market Valuation of USD 357.1 Billion by 2031

September 27, 2024 admin

Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Eyewear Market will reach a value of USD 357.1 Billion by 2031, with a CAGR of 8.4%…

Producers

Fredonia Mining Inc. Announces Closing of $1,000,000 Non-Brokered Private Placement

September 27, 2024 admin

TORONTO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Fredonia Mining Inc. (TSXV: FRED) (the “Company” or “Fredonia”) is pleased to announce the closing of its previously announced non-brokered private placement, consisting…

Producers

Crédit Agricole Brie Picardie : Rapport Financier semestriel 2024

September 27, 2024 admin

Rapport Financier semestriel 2024 La Caisse Régionale de Crédit Agricole Mutuel Brie Picardie compte au 30 juin 2024 :• 206 agences de Proximité• 1 agence Gestion de la Relation à…

Producers

Invesco Ltd: Form 8.3 – Rightmove PLC ;Public dealing disclosure

September 27, 2024 admin

PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.KEY INFORMATION (a)Full name of discloser:Invesco Ltd. (b)Owner or controller…

Producers

Global Bispecific Antibodies Clinical Trials Market Size FDA Approved Bispecific Antibodies Insight

September 27, 2024 admin

Delhi, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: Bispecific Antibodies Development Proprietary Platforms Insight: > 30…

Posts pagination

1 … 239 240 241 … 324

Recent Posts

  • Tim Lamb Group Welcomes Paul Gilroy To Their Team of Directors
  • Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
  • Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine
  • Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt
  • Akero Therapeutics présente les résultats de la 96e semaine de l’essai clinique de phase 2b SYMMETRY sur l’éfruxifermine chez des patients atteints de cirrhose compensée causée par une stéatohépatite associée à un dysfonctionnement métabolique (MASH), montrant une amélioration de la fibrose sans aggravation de la MASH lors du congrès 2025 de l’EASL

Producers Online
Producers Online

No comments to show.

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • August 2024

Categories

  • Producers
  • Българо-китайска търговско-промишлена палата

You missed

Producers

Tim Lamb Group Welcomes Paul Gilroy To Their Team of Directors

May 12, 2025 admin
Producers

Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025

May 12, 2025 admin
Producers

Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine

May 12, 2025 admin
Producers

Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt

May 12, 2025 admin

Producers Online

Producers Online

Proudly powered by WordPress | Theme: Newsup by Themeansar.

  • Home
  • Producers online